LUPETTI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.726
EU - Europa 4.120
AS - Asia 3.927
SA - Sud America 658
AF - Africa 131
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.577
Nazione #
US - Stati Uniti d'America 8.499
IT - Italia 1.669
CN - Cina 1.228
SG - Singapore 1.109
HK - Hong Kong 733
BR - Brasile 569
DE - Germania 541
SE - Svezia 489
BG - Bulgaria 275
GB - Regno Unito 219
VN - Vietnam 199
FI - Finlandia 174
CA - Canada 170
KR - Corea 164
TR - Turchia 160
RU - Federazione Russa 159
UA - Ucraina 142
FR - Francia 122
IN - India 96
AT - Austria 77
NL - Olanda 73
JP - Giappone 53
CH - Svizzera 50
CI - Costa d'Avorio 43
BE - Belgio 33
PL - Polonia 31
BD - Bangladesh 28
AR - Argentina 27
IQ - Iraq 26
MX - Messico 23
EC - Ecuador 19
ES - Italia 19
ZA - Sudafrica 19
MA - Marocco 18
MY - Malesia 15
SA - Arabia Saudita 15
VE - Venezuela 12
CO - Colombia 11
CZ - Repubblica Ceca 11
EG - Egitto 11
ID - Indonesia 11
IE - Irlanda 10
PK - Pakistan 10
SN - Senegal 10
NG - Nigeria 9
UZ - Uzbekistan 9
AU - Australia 8
PH - Filippine 8
IL - Israele 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
JM - Giamaica 6
CL - Cile 5
KE - Kenya 5
PA - Panama 5
AZ - Azerbaigian 4
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
TH - Thailandia 4
BB - Barbados 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
QA - Qatar 3
SV - El Salvador 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BJ - Benin 2
DK - Danimarca 2
DZ - Algeria 2
GT - Guatemala 2
HR - Croazia 2
NA - Namibia 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
Totale 17.561
Città #
Ashburn 968
Woodbridge 779
Houston 777
Hong Kong 721
Fairfield 718
Ann Arbor 674
Singapore 662
Santa Clara 548
Chandler 507
Dallas 409
Milan 293
Sofia 274
Seattle 273
Shanghai 270
Wilmington 259
Beijing 249
Serra 241
Cambridge 229
Hefei 191
New York 191
Jacksonville 170
Seoul 163
Pisa 159
Boardman 153
Los Angeles 141
Princeton 141
Munich 138
Ottawa 138
Frankfurt am Main 116
Lawrence 111
Medford 104
Bremen 98
Izmir 92
Nanjing 91
Des Moines 73
Rome 73
Florence 68
London 62
Dearborn 60
Vienna 58
Dong Ket 57
Helsinki 57
Redondo Beach 50
São Paulo 48
Bern 47
Istanbul 44
Abidjan 43
San Diego 43
Buffalo 39
Lucca 39
Tokyo 39
Marseille 37
Nanchang 34
Jüchen 30
Council Bluffs 26
Warsaw 26
Brussels 23
Ho Chi Minh City 23
Redwood City 23
Columbus 20
Kunming 20
Ogden 20
Pune 20
Boulder 19
Rio de Janeiro 19
The Dalles 19
Turku 19
Washington 19
Nuremberg 18
Shenyang 18
Changsha 16
Jiaxing 16
Phoenix 16
Hebei 15
Guangzhou 14
Hanoi 14
Hyderabad 14
San Francisco 14
Chicago 13
Curitiba 13
Lancaster 13
Hangzhou 12
Livorno 12
Belo Horizonte 11
Brasília 11
Lappeenranta 11
Montreal 11
Ankara 10
Boydton 10
Dakar 10
Amsterdam 9
Fuzhou 9
Lagos 9
Naples 9
Norwalk 9
Quanzhou 9
Quarrata 9
Johannesburg 8
Tianjin 8
Auburn Hills 7
Totale 12.723
Nome #
Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates 343
Maternal anthropometric variables and clinical factors shape neonatal microbiome 310
Diagnosis of bloodstream infections by mass spectrometry : present and future 234
Comparative evaluation of antimicrobial activity of different types of ionic liquids 234
Evaluation of a multiplex Real-Time PCR assay for the diagnosis of human intestinal protozoa in Azienda Ospedaliero Universitaria Pisana 234
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 214
Direct inoculation of positive blood cultures using the Phoenix system for antimicrobial susceptibility testing of both Gram-positive and Gram-negative bacteria 210
Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy 198
Identification of Candida albicans karyotypes characterized by a high proteolytic activity. 195
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 194
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 191
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 191
A comparison of skin storage methods for oculoplastic surgery 187
Antimicrobial Activity of a New Aloe vera Formulation for the Hygiene of the Periocular Area 184
Molecular basis of resistance to azole antifungals. 182
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 181
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 180
Effects of Pseudomonas aeruginosa on immune functions. 179
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus 178
Antifungal effect of the antimicrobial peptide hLF(1-11) on invasive infections with Candida albicans. 177
Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice. 176
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 176
Radiopharmaceuticals: new antimicrobial agents 174
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections 173
Recent advances in the microbiological diagnosis of bloodstream infections 172
Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification 171
Comparative evaluation of six chromogenic media for presumptive yeast identification 169
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11 164
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains 164
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 162
Detection of fungal infections using radiolabeled antifungal agents 159
Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system 158
Radiotracers for fungal infection imaging 156
A new culture-based method for rapid identification of microorganisms in polymicrobial blood cultures by MALDI-TOF 155
Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus 152
Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin 151
CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells 150
Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. 149
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin 149
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area 149
Reactivation of Graves' Orbitopathy after Rehabilitative Orbital Decompression 148
Technetium-99m labeled cationic antimicrobial peptides for infection detection and treatment monitoring 147
From positive blood culture to microbiological diagnosis in 4 hours by MALDI-TOF mass spectrometry bacterial identification and rapid antibiogram. 147
Candidacidal activities of human lactoferrin peptides derived from the N terminus 147
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg 146
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 146
99mTc-Antimicrobial peptides: promising candidates for infection imaging 144
Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species 143
Identification of Bacillus species: Implication on the quality of probiotic formulations 143
Graves’ orbitopathy presenting after botulinum toxin injections 142
Control of Candida albicans murine vaginitis by topical administration of polycarbophil-econazole complex 142
Molecular monitoring of Candida albicans infections in liver transplant recipients 142
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections 141
Characterization of the chemotaxis fliY and cheA genes in Bacillus cereus 141
Rapid and reliable identification of Gram-negative bacteria and Gram-positive cocci by deposition of bacteria harvested from blood cultures onto the MALDI-TOF plate. 141
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 141
Identification of Candida albicans karyotypes characterized by a high proteolytic activity 139
Molecular targeted treatments for fungal infections: the role of drug combinations 139
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 139
Radiochemical and biological characteristics of Technetium-99m labelled fluconazole 137
A Rapid Procedure for Identification and Antifungal Susceptibility Testing of Yeasts From Positive Blood Cultures 137
Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 136
A comparison for skin storage methods for oculoplastic surgery 135
FlhF Is Required for Swarming Motility and Full Pathogenicity of Bacillus cereus 134
Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS 133
Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment 133
Caratterizzazione genotipica di Candida albicans 133
Radiolabelled antimicrobial peptides for infection detection 133
99mTc-labelled antimicrobial peptides for detection of bacterial and Candida albicans infections 132
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species 131
Graves’ orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation 130
MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives 130
Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide 130
Internal thiols and reactive oxygen species in the candidacidal activity exerted by a N-terminal peptide of human lactoferrin. 129
Synergistic activity between colistin and the ionic liquids 1-methyl-3 dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1 dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria 129
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 128
Rapid identification and antibiotic susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 System 127
Proteolytic activity and SAP gene expression in Candida albicans strains having different karyotypes 125
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains 123
Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation 123
Imaging of infections with Candida albicans with 99mTc-labelled antimicrobial peptides and the antifungal agent fluconazole. 120
New rapid methods cannot replace the current method to diagnose bloodstream infections. 120
Erratum to: Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy (Frontiers in Medicine, (2018), 5, 10.3389/fmed.2018.00059) 119
null 118
In vitro resistance and evolution of resistance to tavaborole in Trichophyton rubrum 117
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 117
Comparison of molecular typing methods for Candida albicans strain delineation. 115
A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures 115
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 114
Letter to the Editor 112
Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center 110
Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology 110
Anti-Staphylococcal Biofilm Effects of a Liposome-Based Formulation Containing Citrus Polyphenols 109
Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry 109
Technetium-99m labelled antimicrobial peptides and anti-infectives for the detection of bacterial and Candida albicans infections. 108
MOLECULAR TYPING OF CANDIDA-ALBICANS IN ORAL CANDIDIASIS - KARYOTYPE EPIDEMIOLOGY WITH HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS IN COMPARISON WITH THAT WITH HEALTHY CARRIERS 108
Letter to the Editor 106
Diagnosi batteriologica 106
Diagnosi batteriologica. 105
Rapid detection of carbapenem resistant Klebsiella pneumoniae directly from positive blood cultures during an outbreak, in the Tuscany region in Italy. 104
Totale 15.133
Categoria #
all - tutte 52.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021798 0 0 0 0 0 85 72 117 156 73 106 189
2021/20221.256 28 86 16 97 189 154 36 75 80 66 50 379
2022/20231.826 201 193 114 221 244 207 15 136 330 14 130 21
2023/20241.476 138 163 166 106 236 264 43 35 39 65 71 150
2024/20254.647 94 183 84 216 470 436 479 257 420 552 596 860
2025/20262.336 307 589 528 335 499 78 0 0 0 0 0 0
Totale 18.057